TrialAnnals of oncology : official journal of the European Society for Medical Oncology2015

A randomized, controlled phase III trial of nab-Paclitaxel versus dacarbazine in chemotherapy-naïve patients with metastatic melanoma.

E M Hersh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.